Showing results (431-440 of 504) with videos related to

Sort By:
Pageof 51
Cancers|February 11, 2023
COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the OutcomeSyed Rahmanuddin, Asma Jamil, Ammar Chaudhry, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYCHannah T Rosen, Kelvin Li, Erin L Li, et al.
Plos One|September 25, 2024
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.
Leukemia & Lymphoma|June 9, 2011
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphomaChristiane Querfeld, Timothy M Kuzel, Youn H Kim, et al.
Plos One|August 15, 2019
Virtual reality for management of pain in hospitalized patients: A randomized comparative effectiveness trialBrennan Spiegel, Garth Fuller, Mayra Lopez, et al.
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood Advances|February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphomaChristiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
The Journal of Investigative Dermatology|May 15, 2018
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell LymphomaXu Hannah Zhang, Sangkil Nam, Jun Wu, et al.
Pageof 51